Home
Home
Accedi all'area interna
Login
Utente
Password
Entra
Recupera utente e pwd
Cambio utente e password
Per maggiori informazioni sull'evento vai al
sito del Congresso
Web
Poster
CASI CLINICI 1
25 poster
1
Incoordination and diffuse asthenia in a young woman with depression: still a diagnostic challenge.
Roberto Acampora
40
Electroencephalographic paroxysmal abnormalites and cortical dysplasia are not always associated with epileptic seizures: a case of NREM parasomnia in adulthood
Tommaso Baldini
41
Isolated neurological Whipple's disease presenting with rhombencephalits and cervical myelitis.
Claudia Balducci
68
Telestroke network in internal areas of Umbria: the first case of remote assisted thrombolysis
Laura Bernetti
157
Gastric bezoar and duodenal ulcer as complication of Duodopa® therapy in a patient affected by Parkinson's Disease
Paolo Cerrone
209
Anti-SRP Necrotizing Autoimmune Myopathy and Occult Breast Cancer: a case report.
Claudia Cutelle'
244
Giant cell arteritis mimicking vertebral dissection: a case report.
Alessandra Di Liberto
254
Combined central and peripheral demyelination mimicking Bing-Neel syndrome in Waldestrom macroglobulinemia: a case of successful treatment with Prednisone
Vincenzo Di Stefano
287
Left hemispheric status epilepticus with crossed cerebellar diaschisis
Michela Ada Noris Ferilli
293
SPONTANEOUS INTRACRANIAL HYPOTENSION CAUSING SINUS DURAL ARTERIOVENOUS FISTULA
Enrico Ferrante
299
A case of facioscapulohumeral muscular dystrophy and myasthenia gravis with positivity of anti-Ach receptor antibody: a fortuitous association?
Enrica Filippelli
320
Rescue therapy with alemtuzumab in Multiple Sclerosis post-natalizumab puerperium reactivation
Jessica Frau
345
Diagnostic challenges in a patient with progressive encephalopathy and MRI changes undergoing immunosuppression for GVHD after allogeneic HSCT
Ginevra Giovannelli
438
HEAD TREMOR ASSOCIATED WITH UNILATERAL REST TREMOR: ET, PD OR OTHER?
Manuela Mancini
445
Atypical parkinsonisms in the clinical course of progressive multiple sclerosis
Antonio Marangi
463
Acute spinal cord lesion in a 5-years-old Leber's Hereditary Optic Neuropathy
Eleonora Mauri
468
DYSTONIC MOVEMENTS OF THE PARAVETEBRAL MUSCLES AFTER MULTIPLE REPETITIVE SURGERY TREATED WITH BOTULINUM TOXIN
Giulia Mazzon
479
Visual streams' hallucinosis. Characterization of Charles Bonnet syndrome due to lesions localized in the visual system
Laura Mirandola
496
COPPER DEFICIENCY AS AN UNUSUAL CASE OF LONGITUDINALLY EXTENSIVE MYELOPATHY. A CASE REPORT
Carlotta Mutti
512
Three consecutive cases of Herpes simplex virus encephalitis despite normal cell count in the cerebrospinal fluid
Graziamaria Nuzzaco
547
Early relapses in Cerebral Amyloid Angiopathy-Related Inflammation: a case report.
Giulia Perini
673
Forehead Tremor: a clinical presentation of ocular Myasthenia Gravis?
Giorgia Sciacca
674
Subacute combined degeneration due to vitamin B12 deficiency in the absence of macrocytic anemia.
Giorgia Sciacca
685
Follow-up of three patients with multiple sclerosis developing IFN beta-induced atypical hemolytic uremic syndrome and treated with Eculizumab.
Francesco Silvestre
694
The Effects of Deferiprone in Superficial Siderosis: a case report
Maria Teresa Sollazzo
CASI CLINICI 2
31 poster
622
Toxoplasma encephalitis in a young immunocompetent man with ischemic stroke as initial presentation
Angela Romano
761
Posterior reversible encephalopathy: a blood transfusion related case
Erica Viani
770
Type 1 Narcolepsy in anti-Hu antibodies mediated encephalitis: a case report
Maria Vitiello
774
Sixth nerve and superior division of third nerve palsy due to intracranial extension of multiple myeloma. A “stroke mimic" diagnostic challenge.
Domenica Zaino
533
Benign intracranial hypertension in children can be due to hypoparathyroidism: a case-report
Laura Papetti
554
IDIOPATHIC BASAL GANGLIA CALCIFICATION WITH ALTERED IOFLUPANE SPECT AND GOOD RESPONSE TO L-DOPA TREATMENT: A CASE REPORT
Marco Piatti
582
STIFF LIMB SYNDROME: AN UNUSUAL PRESENTATION
Alessandra Pulcini
507
A case of high-grade glioma with extremely rapid progression originating from cavernous sinus
Alessio Novelli
439
Aseptic meningitis: a rare complication in a patient on etanercept therapy for rheumatoid arthritis
Chiara Manfredi
450
ANCA-associated systemic vasculitis presenting with hypertrophic pachymeningitis: a case report
Federico Marrama
451
MOTOR NEURON AND PARKINSON'S DISEASE COMPLEX: A CASE REPORT OF A BRAIT-FAHN-SCHWARZ DISEASE.
Daniele Martinelli
256
Spontaneous intracranial hypotension or Neurosarcoidosis: that is the question! A case report.
Ilaria Antonella Di Vico
229
Anti- Ma2-associated opsoclonus-ataxia syndrome
Giovanna De Michele
197
MC CUNE ALBRIGHT STERNBERG
Maria Sofia Cotelli
183
Cocaine-induced toxic leukoencephalopathy: a case report
Elena Contaldi
184
Detection of CSF antiGluR3 antibodies in a patient with behavioral impairment without epilepsy: a case report
Elena Contaldi
186
YOUNG WOMAN WITH MULTIPLE SCLEROSIS AND SYSTEMIC LUPUS ERYTHEMATOSUS: CONTRIBUTION TO DIFFERENTIAL DIAGNOSIS BY BRAIN MRI USING T2*SEQUENCES.
Margherita Contento
193
Transitory and floating aphasic disease in a patience affected by Thrombotic Thrombocytopenic Purpura (Moschcowitz Syndrome)
Manuela Costa
167
An uncommon presentation of antiphospholipid antibody syndrome
Ludovico Ciolli
121
HERPES SIMPLEX VIRUS TYPE 1 ENCEPHALITIS AND BRAIN GLIOMA: CASE REPORT
Giorgio Caneve
139
A severe overlap case of Miller Fisher and the pharingeal-cervical-brachial variant of Guillain Barrà© Syndrome
Barbara Casolla
73
Progressive multifocal leukoencephalopathy: four cases of JCV infection in iatrogenic immunocompromised patients
Alessia Bianchi
79
Hashimoto's encephalopathy a rare disorder: Case report
Fabiola Bologna
54
Transauricular and then invasive successful Vagus Nerve Stimulation treatment in drug resistant epilepsy: a case-report
Giuseppina Barbella
55
A rare case of scleromyxedema complicated by neurological manifestations
Filomena Barbone
52
Internal carotid artery dissection presenting as multiple cranial nerve palsy
Francesco Barbato
82
Improving SMARD1 long-term outcome and quality of life: the role of a multidisciplinary setting
Carmen Bonanno
100
Cerebral air embolism as a complication of idiopathic pulmonary fibrosis. A case report.
Nicoletta Brunelli
104
Ophthalmoplegia due to Miller Fisher Syndrome in a patient with Myasthenia Gravis
Roberta Brusa
44
UNILATERAL PILOERECTION IN MESENCEPHALIC AND HYPOTHALAMIC CONTROLATERAL HEMORRAGE: A CASE REPORT AND NEUROANATOMICAL CONSIDERATIONS
Roberta Balestrino
48
Post-surgical Reversible Cerebral Vasoconstriction Syndrome in a pediatric patient with Chiari I Malformation
Paola Banfi
CASI CLINICI 3
28 poster
165
Atypical parkinsonism overlapping motor neuron disease: presentation of a clinical case open
Daniela Ciaccio
234
Bithalamic stroke due to occlusion of Percheron's artery
Luigi Del Gaudio
291
A trigeminal involvement as unusual feature in a patient with Susac syndrome.
Camilla Ferrante
331
An isolated hypoglossal nerve palsy following pharyngitis: a case report
Annamaria Gallone
332
Isolated neurosarcoidosis: a case report
Annamaria Gallone
316
Colchicine administration may induce isolated and reversible cranial mononeuropathy: a case report
Alessandra Fratto
360
Immune-mediate cerebellar ataxias in children: a case report"
Stefania Graziano
390
THE USE OF BTS NIRVANA IN THE SENSORY STIMULATION OF A MINIMAL RESPONDER'S SUBJECT: A CASE REPORT
Desirè Latella
391
A case of progressive disabling sensorymotor axonal-demyelinating polyneuropathy and severe vascular encephalopathy in a patient with Polyglandular Autoimmune Syndrome Type-4 and positivity of p-ANCA and anti-GAD antibodies.
Domenico Laterza
402
MEIGE SYNDROME: FULL RECOVERY AFTER LIVER TRANSPLANTATION
Chiara Leta
444
Anti-SRP associated necrotizing autoimmune myopathy and multiple sclerosis: a case report
Antonio Marangi
428
ATYPICAL FEATURES IN MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY: REPORT OF TWO CASES
Antonino Lupica
465
Reversible Cervical Vasoconstriction syndrome presenting as recurrent thunderclap headache
Maria Rosaria Mazza
575
The importance of hair testing for benzodiazepines in a suspected casse of idiophatic recurrent study
Emanuela Postiglione
605
Progressive bilateral tongue atrophy: a case of misdiagnosed motor neuron disease
Dario Ricciardi
610
A case of internal carotid hypoplasia
Marianna Riolo
612
A case of unilateral headache and lower cranial nerve palsy.
Marianna Riolo
546
Delayed posthypoxic leukoencephalopathy: a new case of a rare reversible white matter disease
Giulia Peppoloni
563
Cognitive and psychiatric alterations in facioscapulohumeral muscular dystrophy: a case report
Chiara Pizzamiglio
766
Migrainous Infarction: a rare condition associated to reversible vasoconstriction
Luisa Vinciguerra
767
The occurrence of an inflammatory-demyelinating disease in two patients with Neurofibromatosis type 1.
Eleonora Virgilio
720
PROGRESSIVE SPASTIC PARAPARESIS WITH CEREBELLAR ATAXIA: A CASE OF HEREDIATRY SPASTIC PARAPLEGIA CAUSED BY MUTATION IN THE SPG7 GENE
Federica Terenzi
728
An unexpected recovery from vegetative state after a long-time period: the role of cognitive rehabilitation
Michele Torrisi
623
VISUAL IMPAIRMENT AS ATYPICAL PRESENTATION OF CADASIL
Carmela Romano
628
CALRETICULIN MUTATION IN A CASE OF MYOPATHY
Fabiana Rossi
633
CHARCOT-MARIE-TOOTH NEUROPATHY MISDIAGNOSED AS CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY: A CASE SERIES.
Marta Ruiz
688
Tacrolimus-induced severe leukoencephalopaty: evidence for an immune-mediated pathogenesis
Carmelo Luca Smeralda
676
A young woman with central nervous system inflammatory disease diagnosed with thyroid papillary carcinoma
Giuseppe Scopelliti
CASI CLINICI 4
25 poster
663
Neuromyelitis Optica Spectrum Disorder associated to Parsonage Turner Syndrome. Casual or causal connection? A case report.
Gaspare Scaglione
769
Viral encephalitis in Parry Romberg Syndrome: a case report.
Michela Vitale
742
NEUROLOGICAL PRESENTATION OF PARVOVIRUS B19 INFECTION: DESCRIPTION of TWO PEDIATRIC CASES.
Celeste Tucci
759
Systemic vasculitis and nonsystemic vasculitic neuropathy (NSVN)
Elena Pinuccia Verrengia
611
A case of pituitary apoplexy mimicking meningitis
Marianna Riolo
599
An Atypical case of Posterior Reversible Encephalopathy in a Multiple Sclerosis Patient
Roberta Renie
595
MOBILE PHONE HEADACHE: IS THERE A RELATIONSHIP WITH ALTERED CSF PRESSURE?
Laura Rapisarda
576
Idiopathic intracranial hypertension (IIH) associated with hormonal therapy in a male patient: a case report.
Elio Prestipino
501
Unusual visual field defect in glaucoma: a case report
Giulia Nastasi
398
The effect of a virtual training with BTs- Nirvana in post-stroke aphasia: a case study
Simona Leonardi
396
Myasthenia gravis in secondary progressive multiple sclerosis: an underestimated comorbidity?
Elisabetta Lecchi
362
AN UNUSUAL ASSOCIATION OF COGAN'S AND CHURG STRAUSS SYNDROME
Matteo Grazzini
321
IS IT JUST A BRAIN ISCHEMIA? A case report.
Erica Frezza
337
Reversible Cerebral Vasoconstriction Syndrome (RCVS) after epidural steroid injection: a case report
Antonio Genovese
341
A case of ductal-invasive breast carcinoma presenting as first manifestation with right brachial plexopathy
Elisa Giorli
289
A case of chronic relapsing inflammatory optic neuropathy in a young girl: which diagnosis?
Delfina Ferrandi
258
Non-familiar case of relapsing neuralgic amyotrophy with paediatric onset
Alessandro Dinoto
261
A case of Klippel-Trenaunay associated with a Radiologically Isolated Syndrome suggestive of demyelinating disease.
Eugenio Distaso
236
A case of non-fluent aphasia as presenting feature of brain arterovenous malformation
Giulio Demonte
222
Fetal-Type Variants of the Posterior Cerebral Artery and concurrent infarction in the Major Arterial Territories of the Cerebral Hemisphere due to stent occlusion
Jolanda De Caro
223
THE EFFECTS OF COGNITIVE PC-BASED TRAINING IN PARKINSON'S SUBJECT: CONSIDERATIONS ABOUT A CASE STUDY.
Rosaria De Luca
246
A case of subacute beri-beri polyneuropathy associated with Wernicke's encephalopathy?
Salvatore Di Marco
158
Recurrent ischemic stroke and recent menhorragia in a patient affected by antiphospholipid syndrome and LES: a difficult therapeutic choice
Paolo Cerrone
31
Multidomain dementia and olivopontocerebellar atrophy: an unusual presentation of dural arteriovenous fistula
Federica Azzolini
53
Acute Subdural Hematoma without concomitant Subarachnoid Hemorrhage: A Case Report
Giuseppina Barbella
CEFALEE
26 poster
109
ONABOTULINUMTOXIN A IN CHRONIC MIGRAINE: SAFETY AND EFFICACY AFTER TWO YEARS OF TREATMENT
Calogera Butera
49
Dopaminergic symptoms in migraine: a case series on 446 consecutive patients.
Piero Barbanti
50
Increased thrombophilic predisposition in premenopausal females with chronic migraine.
Piero Barbanti
29
Patent foramen ovale, interatrial septal aneurysm and clinical features in migraine with aura: a retrospective analysis.
Federica Assenza
149
PROBABLE REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME. A CASE REPORT
Bruno Censori
136
Daith piercing in a case of chronic migraine: a possible vagal modulation
Angelo Cascio Rizzo
188
Lateral inhibitory mechanisms within the somatosensory cortex in chronic migraine: correlations with clinical features
Gianluca Coppola
221
Thunderclap headache PRES-related during puerperium in patient with tension-type headache: a real case
Fausto De Angeli
281
Greater occipital nerve injections of methylprednisolone alone or in combination with lidocaine in episodic and chronic cluster headache
Valentina Favoni
376
Pituitary enlargement and asymptomatic pituitary hemorrhage as complication of Spontaneous Intracranial Hypotension: critical issues in differential diagnosis.
Alessandro Introna
400
EFFORT HEADACHE AS THE ONLY SYMPTOM OF CEREBRAL VENOUS THROMBOSIS: A CASE REPORT WITH REVIEW OF LITERATURE
Ruggiero Leone
466
Subcutaneous regional targeted botulinum toxin injection technique for the treatment of chronic migraine: a randomized, sham-controlled study
Maria Rosaria Mazza
464
Pressure-related symptoms of isolated CSF hypertension in headache sufferers
Maria Rosaria Mazza
475
Diagnostic evaluation of Headache in Emergency departments: are we doing enough?
Elena Merli
459
OnabotulinumtoxinA treatment in patients with chronic migraine: a retrospective observational study.
Vincenzo Mastrangelo
446
Migraine does not affect pain intensity perception: a cross-sectional study
Laura Marcuccio
598
Retinal fiber layer and choroid thickness are reduced in cluster headache: results from a Optical Coherence Tomography study
Ester Reggio
607
Efficacy of Onabotulinumtoxin A and physical therapy in patients with chronic migraine.
Mariana Ridolfi
534
HANDL SYNDROME IN PEDIATRIC AGE
Laura Papetti
532
Frequency and clinical implications of hypercoagulability states in a cohort of patients with MA
Matteo Paolucci
760
MEDICATION-OVERUSE HEADACHE MANAGEMENT: DATA FROM A MULTICENTRIC CLINICAL STUDY
Angela Verzina
666
Chronic migraine and sleep quality: benefit of deep transcranial magnetic stimulation (dTMS)
Paola Scatena
686
A subjective cognitive impairments scale for migraine attacks: validation of the Italian version of the MIG-SCOG
Marcello Silvestro
687
Idiopathic hypertrophic pachymeningitis mimicking hemicrania continua: an unusual clinical case
Marcello Silvestro
625
Brain white matter and infarct-like lesions in migraine and other primary headache: an Italian single centre study
Michele Romoli
626
Stopping Botox after 2 cycles might not be justified: results of a real-life monocentric prospective study in chronic migraine
Michele Romoli
CEFALEE
1 poster
752
Features of chronic primary headaches (CPH) in children and adolescents referred to two third level headache centers
Massimiliano Valeriani
DEMENZA E INVECCHIAMENTO 1
17 poster
736
Neurological soft signs in dementia: an adjunct tool for global screening?
Lucio Tremolizzo
616
Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in dementia with Lewy bodies
Giovanni Rizzo
648
The immediate copy of the Rey-Osterrieth Complex Figure as a measure of executive functioning in vascular and neurodegenerative MCI patients
Emilia Salvadori
652
Identification of blood biomarkers for early diagnosis of Alzheimer's disease through NMR spectroscopy
Pasquale Sanginario
659
Prodromal Alzheimer's disease presenting with early and prominent dyscalculia
Dario Saracino
678
5-HTTLPR polymorphism and delusions in Alzheimer's disease
Davide Seripa
568
The role of acetylcholine on the ß-amyloid-induced cPLA2 activation in the neuroectodermal cell line TB: implications in the pathogenesis of Alzheimer's disease.
Arianna Polverino
470
Isolated theory of mind deficits and risk for frontotemporal dementia: a five years follow-up
Riccardo Fabrizio Meli
350
The relationship between homocisteine and cognitive profile in Alzheimer's Disease
Francesca Girelli
325
Sulcal opening in behavioural variant Frontotemporal dementia: comparison between automated and manual measures
Giorgio Fumagalli
203
Low levels of proteasome and acyl-peptide hydrolase (APEH) activities in erythrocytes of Alzheimer's patients: a marker of defective proteostasis?
Gloria Cristofano
151
DIFFERENTIALLY EXPRESSED mRNAS/MICRORNAS IN EXTRACELLULAR VESICLES OF ALS AND AD PATIENTS.
Cristina Cereda
168
Neurovascular dysfunction in Alzheimer's disease: assessment of cerebral vasoreactivity by ultrasound techniques and evaluation of endothelial biomarkers
Virginia Cipollini
42
SENSORY SYMPTOMS IN ADVANCED PARKINSON DISEASE: THE EFFECT OF DEEP BRAIN STIMULATION
Roberta Balestrino
107
Clinical and cognitive features distinguishing behavioural frontotemporal dementia from its phenocopy syndrome
Cinzia Busse'
108
The sensitivity of cueing index of the FCSRT may distinguish mild cognitive impairment converting to dementia with Lewy bodies from Alzheimer's disease
Cinzia Busse'
57
REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION (rTMS) COMBINED WITH COGNITIVE TRAINING IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT: A RANDOMIZED CONTROLLED CLINICAL TRIAL
Federica Barocco
DEMENZA E INVECCHIAMENTO 2
12 poster
141
Use of neuroleptics in patients with dementia: clinical experience in a group of patients admitted to an outpatients dementia clinic of azienda sanitaria locale rm2
Teresa Catarci
200
Nutritional status assessed by bioimpedance vector analysis in Alzheimer's dementia: a longitudinal study.
Ilaria Cova
205
EFFECT OF HOMOTAURINE ON FUNCTIONAL ABILITIES IN PATIENTS WITH MILD-TO-MODERATE ALZHEIMER'S DISEASE TREATED WITH A CHOLINESTERASE INHIBITOR THERAPY
Eduardo Cumbo
207
Preliminary investigation of the effects of Relational Training Intervention on cognition in patients with mild-to-moderate Alzheimer's disease treated with a cholinesterase inhibitor therapy
Eduardo Cumbo
298
Eight-hours adaptive deep brain stimulation (aDBS) in Parkinson's disease does not impair cognitive performances
Roberta Ferrucci
259
The personality traits associated with Alzheimer's Disease: a meta-analysis
Alfonsina D'Iorio
231
AN ATYPICAL ASSOCIATION BETWEEN CREUTZFELD-JAKOB DISEASE AND ANTI-AMPHIPHYSIN ANTIBODIES: A CASE REPORT
Giuseppe De Santis
513
A case series of “atypical" atypical Alzheimer's disease: the key role of in vivo markers of neurodegeneration
Mariano Oliva
571
A case of catatonia in a patient with bvFTD: insight into a shared physiopathology and treatment.
Sara Pompanin
665
CSF Aß40/42 ratio correlates with plasmatic LDL levels.
Eugenia Scaricamazza
651
TRIPACTKEL (KELATROX TM) IN VASCULAR SUB-CORTICAL DEMENTIA
Giuseppe Sanges
656
Treating a human neuroectodermal cell line with retinoic acid induces the appearance of neuron-like voltage-gated ionic currents.
Silvia Santillo
DISORDINI DEL MOVIMENTO 1
19 poster
614
Vitamins B during LCIG infusion: possible strategy to reduce peripheral neuropathy
Vittorio Rispoli
671
Clinical significance of CSF biomarkers in Progressive Supranuclear Palsy
Tommaso Schirinzi
693
TREMOR AND OTHER MOVEMENT DISORDERS IN PATIENTS AFFECTED BY KLINEFELTER SYNDROME
Paolo Solla
609
Increased lower limb muscle coactivation and its relationship with gait performance and metabolic cost in patients with hereditary spastic paraparesis
Martina Rinaldi
508
Relationship between hippocampal subfields and category cued recall in AD and PDD: a multimodal MRI study
Fabiana Novellino
492
Progressive supranuclear palsy-parkinsonism evolving from Parkinson disease: a follow-up study
Maurizio Morelli
458
Cognitive onset Parkinson's disease or prodromal DLB?
Federico Massa
453
Crossed cerebellar diaschisis in corticobasal syndrome
Tommaso Martino
430
Non-motor symptoms in Essential Tremor-Parkinson's Disease (ET-PD) Syndrome
Angela Lupo
243
Neurophysiological analysis of vestibular system and postural abnormalities in Parkinson's disease
Giulia Di Lazzaro
228
Clinical predictors of impulse control disorders in drug naive patients with Parkinson's disease
Rosa De Micco
225
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders
Antonio De Mase
267
Grey matter atrophy in Parkinson's disease with Mild Cognitive Impairment: a VBM study.
Giulia Donzuso
312
NEUROPSICHIATRIC DIMENSION OF FOCUS DYSTONIAS: A QUALITATIVE ANALYSIS
Giovanni Flamma
353
Juvenile parkinsonism with jerky movements: a case report
Nico Golfrè Andreasi
144
Lethargic state as a result of abrupt apomorphine withdrawal in Parkinson's disease patients
Francesco Cavallieri
80
Cervical Dystonia Mimicking Dropped Head Syndrome
Roberto Bombardi
33
Personality profile associated with Parkinson's Disease: a meta-analysis
Chiara Baiano
30
TRANSCRANIAL DIRECT CURRENT STIMULATION (t-DCS) AND SPINAL DIRECT CURRENT STIMULATION (s-DCS) FOR TREATMENT OF GAIT DISORDERS IN PARKINSON'S DISEASE: A PILOT TRIPLE CROSS-OVER STUDY
Micol Avenali
DISORDINI DEL MOVIMENTO 2
14 poster
7
Long term efficacy of Botulinum toxin in blepharospasm: a 27 year retrospective study
Cosimo Allegra
43
SENSORY SYMPTOMS IN ADVANCED PARKINSON DISEASE: THE EFFECT OF INTREJEJUNAL LEVODOPA CARBIDOPA INFUSION
Roberta Balestrino
192
ACUTE DYSTONIA AND SSRI TREATMENT: A CASE REPORT
Alina Cormio
275
Speech and voice response to a levodopa challenge in late-stage Parkinson's disease patients
Margherita Fabbri
279
LEVODOPA RESPONSIVE PARKINSONISM WITH ABNORMAL BRAIN DATSCAN SPECT IN DOWN'S SYNDROME: A CASE REPORT
Rita Farris
253
Levodopa Equivalent Daily doses in advanced Parkinson's Disease: gender and the anthropometric predictors.
Alessandro Di Santo
249
Assessment of the need and use of smart and new technologies in Parkinson's disease
Chiara Di Nuzzo
436
THERAPEUTIC RHYTHMIC AS A COGNITIVE INTERVENTION FOR PARKINSON'S DISEASE
Francesca Mameli
506
Respiratory function in Parkinson's disease
Pasquale Nigro
489
Parkinson's disease: a study on the role of doctor-patient communication discussing the transition to complex therapies.
Elisa Montanaro
556
Decreased reactive motor control and increased impulsiveness in Parkinson's disease patients with levodopa-induced dyskinesias
Silvia Picazio
523
Freezing of gait in parkinsonism: is an early predictor of cortical dementia?
Giovanni Palermo
668
Dopamine Striatal binding and cognition in Parkinson's disease
Francesca Schiano Di Cola
722
[123I]FP-CIT SPECT and clinical features in early idiopathic normal pressure hydrocephalus: comparison with newly diagnosed Parkinson's disease
Massimiliano Todisco
DISORDINI DEL MOVIMENTO 3
16 poster
615
Paroxysmal NonKinesigenic Dyskinesia (PNKD) in a 27-year-old man patient with Multiple Sclerosis (MS) at clinical onset
Romana Rizzi
621
Autonomic dysfunction causes disability in Parkinson disease: a prospective study
Alberto Romagnolo
655
Relationship between apathy and executive dysfunctions in Parkinson's Disease
Gabriella Santangelo
632
No effects of cerebellar and spinal DC stimulation on P300 component during auditory oddball task
Fabiana Ruggiero
566
Thalamic tremor as onset of vascular parkinsonism
Serena Polidoro
493
Electrocortical Connectivity and Non-linear Quantitative Analysis of EEG Signal in PD-MCI.
Giovanni Mostile
495
Functional cervical dystonia: from the diagnosis to treatment, what we appraised from a clinical history.
Delia Mulas
250
SCA 17 presenting as a dominant choreic syndrome: a case report
Andrea Di Paolantonio
269
Emi-rabbit syndrome caused by chronic use of cinnarizine
Tommaso Ercoli
401
Cognitive training in Parkinson's Disease: a pilot randomized controlled trial
Chiara Leta
404
Effective treatment of resistant Restless Legs Syndrome by Safinamide in a Parkinson's Disease patient.
Claudio Liguori
379
ESSENTIAL TREMOR DISAPPEARED AFTER LUMBAR PUNCTURE. A CASE REPORT.
Aniello Iovino
181
STUDY ON THE CORRELATION AMONG TOTAL BURDEN OF NON-MOTOR SYMPTOMS AND CARDIOVASCULAR DYSMODULATION IN PARKINSON'S DISEASE PATIENTS
Giulia Coni
199
Nutritional evaluation in Parkinson's disease patients: a cross-sectional study.
Ilaria Cova
125
Myopathological features of McLeod Syndrome: a case report
Guglielmo Capaldo
60
Frequency and Correlates of Subjective Memory Complaints in Parkinson's disease subjects with and without Mild Cognitive Impairment: the PArkinson's disease Cognitive impairment Study
Roberta Baschi
Dolore - Sonno - Riabilitazione Neurologica e neurotraumatologia
10 poster
25
Role of vitamin D on a cohort of patients with obstructive sleep apnea (OSA) with and without excessive daytime sleepiness (EDS).
Irene Aricò
106
RISK OF SEIZURE RECURRENCE IN JUVENILE MYOCLONIC EPILEPSY: THE ROLE OF SLEEP
Laura Buratti
135
The APP-Coo-Test: a new method for assessment of coordination of upper limbs in patients with Cerebellar ataxias (CA)
Carlo Casali
173
Validation of stroop color word test as a cognitive task for evaluating cognitive motor interference during walking in Multiple sclerosis.
Giancarlo Coghe
180
Intensive neurorehabilitation is associated with improved fatigue and depression in patients with progressive MS
Martina Congiu
377
Combined transcranial direct current and transorbital alternated current stimulations improve visual function in a case of bilateral optic atrophy
Francesco Iodice
455
PREVENTION OF NEUROTOXICITY WITH DOCOSAHEXAENOIC ACID AND ALPHA LIPOIC ACID IN PATIENTS WITH MULTIPLE MYELOMA: PRELIMINARY DATA
Marta Maschio
564
Neuroradiological characterization of multiple sclerosis patients with chronic pain
Domenico Plantone
662
Task-oriented upper limb motor rehabilitation in Progressive MS: study design and preliminary results
Elvira Sbragia
771
Spinal inhibition of the nociceptive input by higher frequency non-painful stimuli
Catello Vollono
EPILESSIA 1
13 poster
738
Brand-to-Generic Levetiracetam Switching: Catanzaro's epilepsy center experience
Michele Trimboli
713
Post-stroke seizure
Lara Stragapede
511
Effects of Direct Current Stimulation (tDCS) in Pharmacoresistent Focal Epilepsy
Bruna Nucera
460
Structural connectome abnormalities of Non-Lesional Frontal Lobe Epilepsy
Giovanni Mastroianni
420
EPILEPTIC ENCEPHALOPATHY WITH MENTAL RETARDATION AND CEREBELLAR HYPOPLASIA: A CASE REPORT
Andrea Lorusso
352
Abnormal visual connectivity in Eyelid Myoclonia with Absences: evidences from Electrocortical Connectivity study and Non-linear Quantitative Analysis of EEG Signal
Loretta Giuliano
280
Eyelid myoclonia with absences: main features and prognostic factors
Daniela Fatuzzo
297
Is genetic etiology an absolute contraindication for epilepsy surgery? Description of two patients with genetic-related epilepsy who underwent pre-surgical study.
Lorenzo Ferri
252
Epileptic patients' cognitive assessment with the Addendbrooke Cognitive Examination test Revised
Alessandro Di Santo
257
Adult-onset epilepsy in presymptomatic Alzheimer's disease: a retrospective study.
Jacopo C. Difrancesco
143
Old versus New ILAE Seizure Classification: 100 first seizures head to head analysis.
Salvatore Maria Cavalli
137
PITFALLS IN NON-CONVULSIVE STATUS EPILEPTICUS DIAGNOSIS: CREUTZFELDT-JAKOB DISEASE
Angelo Cascio Rizzo
28
How sleep EEG is performed in epilepsy diagnosis ? An online survey among Italian neurophysiologists.
Michele Ascoli
EPILESSIA 2
11 poster
67
Management and treatment of Status Epilepticus: a retrospective study.
Daniela Bernardo
206
Effects of long-term antiepileptic drug monotherapy on the serum levels of Homocisteine and Folic Acid: a retrospective chart review in patients with focal seizures
Eduardo Cumbo
219
Perampanel for the treatment of focal pharmacoresistant epilepsy: the “real life" experience of our center
Chiara Davassi
393
Eslicarbazepine acetate in refractory partial-onset epilepsy: a time-based analysis
Simona Lattanzi
427
The spectrum of orbito-frontal seizures: a SEEG-study
Concetta Luisi
433
Juvenile Myoclonic Epilepsy. Clinical features and prognostic factors in a group of patients
Greta Mainieri
456
Quality of life in patients with brain tumor-related epilepsy versus non oncological epilepsy patients: preliminary data of a retrospective study
Marta Maschio
454
Perampanel as add-on in patients with brain tumour-related epilepsy: a preliminary report
Marta Maschio
592
Clinical and MRI features in Southern Italy cases of Autoimmune Epilepsy
Silvia Giovanna Quitadamo
740
CHD2 mutation: only epilepsy? Description of cognitive and behavioral profile in a case with a new mutation
Serena Troisi
743
Focal epilepsy in patient with a de novo Xq25 duplication
Giulia Turchi
MALATTIE CEREBROVASCOLARI 1
13 poster
762
Mothership versus drip and ship organizations: a probability model
Simone Vidale
763
Pre-hospital stroke scales to predict large vessel occlusion: a meta-analysis of diagnostic accuracy
Simone Vidale
721
INCREASING PREVALENCE OF ATRIAL FIBRILLATION IN PATIENTS WITH FIRST EVER ISCHEMIC STROKE OVER TWO DECADES
Cindy Tiseo
647
Effect of attention training in MCI patients with subcortical vascular changes. The RehAtt Study
Emilia Salvadori
544
HIRATA DISEASE AND INTRACRANIAL VESSELS HYPOPLASIA: A CASE OF STROKE MIMIC IN A YOUNG PATIENT.
Giulia Pellicciari
392
Electrocardiographic assessment in Embolic Strokes of Undetermined Source
Simona Lattanzi
375
CONCOMITANT ISCHEMIC STROKE AND CONVEXITY SUBARACHNOID HEMORRHAGE: A RARE ASSOCIATION.
Alessandro Introna
233
CONTRIBUTION OF DIABETES MELLITUS TO FIRST-EVER ISCHEMIC STROKE: RESULTS FROM A POPULATION-BASED STUDY
Diana Degan
300
Acute Ischemic Stroke in subjects on new direct oral anticoagulants
Cinzia Finocchi
189
DURAL ARTERIOVENOUS FISTULAS: DATA FROM AN OBSERVATIONAL STUDY
Llenia Corbelli
37
HOSPITAL-DISCHARGE-DATA UNDERESTIMATE HEMORRHAGIC STROKE EVENTS: data from a multicenter validation survey in the Florence area (Italy).
Marzia Baldereschi
46
Management of acute ischemic stroke at Policlinic Hospital San Martino in Genoa: from epidemiology to therapy
Monica Bandettini Di Poggio
26
Cerebrovascular disease in a Sicilian elderly community: results from a population based study
Paolo Aridon
MALATTIE CEREBROVASCOLARI 2
20 poster
45
Causative Classification of stroke System (CCS) to investigate pathogenesis of ischemic stroke in Fabry disease: a pilot experience
Gabriele Bambagioni
175
Cerebral vasoreactivity and intima-media thickness in Down Syndrome: a case-control study
Margherita Colella
145
Carotid plaque progression over 4 years in patients with mild and severe stenosis
Gianluca Cecchi
147
FEATURES AND TRENDS IN ENDOVASCULAR TREATMENT FOR ISCHEMIC STROKE AT PAPA GIOVANNI XXIII HOSPITAL
Bruno Censori
148
INCIDENCE OF OROLINGUAL ANGIOEDEMA AFTER INTRAVENOUS THROMBOLYSIS FOR STROKE
Bruno Censori
290
Acute carotid artery stenting in patients with high grade stenosis of carotid internal artery (ICA) presented with acute cerebrovascular accident. A single center experience.
Delfina Ferrandi
292
POSSIBLE CLINICAL MARKER OF FIRST ATTACK OF SPORADIC HEMIPLEGIC MIGRAINE (HM) AND NEUROLOGICAL DEFICITS WITH CEREBROSPINAL FLUID LYMPHOCYTOSIS (HaNDL) (STROKE-LIKE SYNDROMES) IN EMERGENCY ROOM: TWO CASE REPORTS
Enrico Ferrante
263
Hyperdense middle cerebral artery and outcome in acute ischemic stroke patients treated with systemic tPA thrombolysis
Marisa Distefano
394
Neutrophil-to-lymphocyte ratio and outcome of acute intracerebral hemorrhage
Simona Lattanzi
306
FOCUS ON FUNCTIONAL ALTERATION TO PREVENT STRUCTURAL DAMAGE
Patrizia Fiori
308
IMMUNOLOGICAL STATUS IN ACUTE STROKE
Patrizia Fiori
309
LOW MOLECULAR WEIGHT PROTEINURIA AND RISK OF ISCHAEMIC SUFFERENCE
Patrizia Fiori
527
Childhood Ischemic Stroke: a not infrequent disease
Maria Pandolfi
569
CT-Perfusion and cerebellar diaschisis in stroke patients
Paola Polverino
550
ACUTE TOP OF THE BASILAR OCCLUSION: A SUCCESSFUL TREATMENT WITH THROMBOLYSIS AND THROMBECTOMY
Giulia Perrotta
600
Ischemic stroke in a young man with active EBV infection
Rosaria Renna
498
Stroke incidence in Bologna's local health area
Federica Naldi
499
Hub and Spoke stroke network in the Veneto Region: a retrospective study investigating the effectiveness of the stroke pathway and trends over time.
Lucia Nardetto
727
Identifying factors associated with hospital readmissions and in-hospital deaths in stroke patients. An exploratory analysis of a single hospital in Ravenna.
Francesca Torelli
751
CORRELATION BETWEEN TOTAL SMALL VESSEL DISEASE BURDEN ON MRI AND IMPAIRMENTS IN STRUCTURAL BRAIN NETWORKS IN PATIENTS WITH CEREBRAL AMYLOID ANGIOPATHY
Raffaella Valenti
MALATTIE CEREBROVASCOLARI 3
16 poster
505
AN INTERNAL CAROTID ARTERY DISECTION PRESENTING WITH FACIAL PERIPHERAL PALSY TREATED WITH ENDOVASCULAR THERAPY.
Ettore Nicolini
606
EARLY REPEATED THROMBOLYSIS IN A RECURRENT STROKE : A CASE REPORT
Mariana Ridolfi
613
Embolic strokes of undetermined source: frequency and patient features in a hospital-based population.
Marianna Riolo
578
SUCCESSUL MECHANICAL THROMBECTOMY FOR BASILAR OCCLUSION IN A PATIENT WITH A 13 HRS ONSET-TO-NEEDLE-TIME
Lucia Princiotta Cariddi
570
Ischaemic Versus Epileptic Aphasia: An Outcome Assessment
Paola Polverino
315
Bilateral Medial Medullary Infarction: a case report.
Roberto Fratangelo
386
BILATERAL AND SIMULTANEOUS MIDDLE CEREBRAL ARTERY INFARCT: A CASE REPORT
Anna Chiara Landi
380
Cerebral venous thrombosis and idiopathic pyastrinopenia: a clinical case
Linda Iurato
283
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME IN ATYPICAL HEMOLYTIC UREMIC SYNDROME
Vincenzo Felica
302
Hemorrhagic stroke in a Nigerian patient with sickle cell trait and high blood pressure
Laura Fionda
255
Insular ischemic stroke: typical clinical presentation and unusual features
Vincenzo Di Stefano
176
Major stroke as a first manifestation of connective tissue disease in young patient with intracranial carotid dissection
Margherita Colella
211
Sharp increase of acute ischemic stroke treatment rates in Aosta Valley after adoption of a stroke-specific protocol and a stroke public awareness campain
Giuseppe D'Alessandro
198
Cardioembolic stroke as first manifestation of complex pathology in haemodyalisis patient
Masina Cotroneo
72
Abnormal left-to right shunt and acute cerebrovascular events in the young: a need for search
Pierluigi Bertora
111
Isolated hypoglossal nerve palsy: have you studied the carotid artery?
Corrado Cabona
MALATTIE DEGENERATIVE
14 poster
84
Prevalence of neuropathy in Friedreich's ataxia patients and in subject heterozygous for GAA trinucleotide repeat in FXN gene
Sara Bortolani
64
AN UNUSUAL PRESENTATION OF SYNE1 MUTATION (ARCA1 – BEAUCE ATAXIA – SCAR8): HYPOGONADISM AND INTELLECTUAL DISABILITY
Marta Bellofatto
66
Therapeutic effect of L-Dopa/Carbidopa Intestinal Gel on dysphagia in Advanced Parkinson's Disease: a pilot study.
Matteo Berenati
9
The impact of Amyloid PET as biomarker of Alzheimer's disease in the differential diagnosis of dementia: a multidisciplinary team study
Pierpaolo Alongi
177
A case of Nasu-Hakola disease with asymptomatic bone lesions due to the homozygous Q33X mutation in TREM2: report of an Italian family and review of the literature
Annalisa Colombi
185
Trunk-lower limb coordination pattern during gait in patients with ataxia
Carmela Conte
245
Impaired Spike Timing Dependent Cortico-Cortical Plasticity in Alzheimer's disease Patients
Francesco Di Lorenzo
242
Low serum uric acid concentration as a risk factor for tauopathies
Giulia Di Lazzaro
490
Non-motor Symptoms in Parkinson's Disease: Comparison of Psychic and Cognitive Symptoms at Different Age of onset of the Disease
Antonella Morea
487
Atypical presentation of non-fluent neurodegenerative aphasia
Nicola Mometto
473
Investigation of neural stem cell biology in a mouse model of Rett syndrome
Marina Melone
737
THE ROLE OF GLUCOCEREBROSIDASE IN NEURODEGENERATION ASSOCIATED TO GAUCHER'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES
Ilaria Trezzi
617
LONGITUDINAL STUDY OF A COHORT OF MSA-C PATIENTS IN SOUTH ITALY: SURVIVAL AND CLINICAL FEATURES
Alessandro Roca
627
Safinamide versus Entacapone in Parkinson disease - results from a prospective multicentre study
Carlo Rossi
MALATTIE DEL MOTONEURONE
20 poster
661
NEUROMUSCULAR ULTRASOUNDS (NMUS) AS SUITABLE DIAGNOSTIC TOOL IN THE ASSESSMENT OF SEVERITY AND DISEASE PROGRESSION OF AMYOTROPHIC LATERAL SCLEROSIS
Ferdinando Sartucci
664
CSF Tau in diagnosis of Amyotrophic Lateral Sclerosis: relation with clinical features.
Antonio Scarafino
712
A novel heterozygote mutation of SLC52A3 in a slowly progressive case of Brown-Vialetto-Van Laere syndrome
Giulia Straccia
734
DBI serum levels in ALS patients correlates with behavioural dysfunction
Lucio Tremolizzo
735
Increased serum TDP43 and anti-TDP43 auto-antibodies in ALS patients
Lucio Tremolizzo
757
Diagnostic and prognostic usefulness of serum neurofilament light chain levels in amyotrophic lateral sclerosis
Federico Verde
589
Deleterious variants of FIG4 gene in a patient with fast progressing ALS phenotype.
Giorgia Querin
590
Measuring Quality of life in patients with Spinal and Bulbar Muscular Atrophy (SBMA).
Giorgia Querin
591
Preliminary design and test of the “6K scale" for Bulbar Symptoms evaluation in patients with SBMA.
Giorgia Querin
284
Whole-Brain HARDI investigation in Bulbar- and Spinal-onset Amyotrophic Lateral Sclerosis
Cinzia Femiano
374
ADHERENCE TO RILUZOLE IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: AN OBSERVATIONAL STUDY.
Alessandro Introna
355
Motor neuron disease: a multimodal longitudinal follow up
Alfredo Granata
328
Dysregulation of miRNA expression in ALS induced Pluripotent Stem Cells-derived motor neurons
Delia Gagliardi
182
Cortical thinning and phenotypic heterogeneity of cognitive and behavioural syndromes in amyotrophic lateral sclerosis
Monica Consonni
204
Paraneoplastic Motor Neuron Disease in a patient with a Natural Killer cells leukemia
Luca Cuffaro
153
LEUKOCYTE DERIVED MICROVESICLES CORRELATE WITH DISEASE PROGRESSION IN ALS.
Cristina Cereda
154
LYMPHOBLASTOID CELL LINES: AN INTERESTING MODEL TO STUDY ALS DISEASE MECHANISM
Cristina Cereda
155
MITOPHAGY IMPAIRMENT IN PBMCS OF SPORADIC ALS PATIENTS.
Cristina Cereda
122
An apparently sporadic ALS patient carrying a novel p.Leu106fs*15 SOD1 mutation causing the formation of a premature stop codon: insights into the underlying pathomechanisms
Antonio Canosa
77
Sjögren-related atypical myositis mimicking respiratory-onset ALS
Silvia Bocci
MALATTIE NEUROMUSCOLARI 1
20 poster
115
CMT2 WITH PYRAMIDAL TRACT INVOLVEMENT DUE TO ARG329HIS MUTATION IN ALANYL-TRNA SYNTHETASE (AARS)
Ilaria Callegari
131
HUMAN LEUKOCYTE ANTIGENS (HLA) IN CIDP SPECTRUM NEUROPATHIES
Filomena Caria
215
Saint Catherina of Genua tribulations. An hystorical case of porphyria?
Francesco D'Alpa
330
Atypical clinical pictures and paucisymptomatic subjects: pitfalls in diagnosing inflammatory myopathies
Serena Gallo Cassarino
351
Specific muscle biopsy findings in necrotizing autoimmune myopathy
Francesco Girolamo
335
Long-term immunosuppressive treatment in immune-mediated neuromuscular disease: data of a multi-centric retrospective observational study
Martina Garnero
336
NATURAL HISTORY OF CHARCOT-MARIE-TOOTH: A 10-YEAR FOLLOW-UP
Chiara Gemelli
266
Lifestyle and dietary habits as predisposing factors for the onset and progression of cidp: a case-control study from the italian cidp database
Pietro Emiliano Doneddu
262
Effectiveness of treatment with ivabradine on clinical and instrumental endpoints in patients with Duchenne Muscular Dystrophy
Maria Grazia Distefano
303
Multifocal Motor Neuropathy following treatment with Adalimumab for Ulcerative Colitis
Laura Fionda
301
Clinical, morphological and immunological findings in myasthenia-myositis association.
Laura Fionda
230
Clinical and serological features of thymoma-associated Myasthenia Gravis: a retrospective analysis on 346 patients
Anna De Rosa
562
CHARACTERIZATION OF LATE-ONSET AXONAL CHARCOT-MARIE-TOOTH TYPE 2I ASSOCIATED WITH THE P70S MUTATION
Chiara Pisciotta
560
A RARE CASE OF MYOPATHY WITH PIPESTEM CAPILLARIES IN A FEMALE CARRIER OF BECKER MUSCULAR DYSTROPHY
Laura Pilati
548
Altered intestinal permeability in Myotonic dystrophy: a possible relationship with nonalcoholic fatty liver disease?
Alessia Perna
423
Sporadic Inclusion Body Myositis and anti-CN1A antibodies: possible relationship with clinical severity in a single centre Italian cohort.
Matteo Lucchini
389
Concurrent atypical paraneoplastic demyelinating polyneuropathy and neuromuscular junction defect in a patient with anti-VGCC antibodies
Caterina Lapucci
677
The role of muscle biopsy in the diagnostic process of rhabdomyolysis: large retrospective study and proposal of a revised diagnostic workflow
Claudio Semplicini
630
Muscle pathological features in a patient with a hypokalemic periodic paralysis/dermatomyositis “double trouble"
Silvia Rota
649
Postural and walking patterns assessed by 3d movement analysis in late onset Pompe disease.
Simone Sampaolo
MALATTIE NEUROMUSCOLARI 2
17 poster
629
Evaluation of predictor factors of respiratory impairment in a cohort of Italian Myotonic Dystrophy type 1 patients.
Salvatore Rossi
753
Charcot-Marie-Tooth disease type-2 associated with two missense mutations in MME gene
Elisa Vegezzi
779
Diagnosis of diabetic neuropathies in a large population of patients accessing primary clinical care
Angela Zuppa
467
A singular case of dropped-head syndrome associated with anti-Pm-Scl myositis.
Marco Mazzoli
488
RISK FACTORS FOR ASYMPTOMATIC DELAY OF MOTOR CONDUCTION VELOCITY OF THE ULNAR NERVE ACROSS THE ELBOW. A MULTICENTER CASE-CONTROL STUDY.
Mauro Mondelli
537
GNE MYOPATHY FUNCTIONAL ACTIVITY SCALE (GNEM-FAS): A FOUR YEAR FOLLOW UP IN 11 HIBM PATIENTS
Daniela Parisi
603
Anti-HMGCoA necrotizing autoimmune myopathy: a case report
Giulia Ricci
604
The development of a mobile app for patients with Pompe disease and its possible clinical applications.
Giulia Ricci
232
Plasma-exchange responsive tardive delayed pseudochoreoathetosis in a patient with anti-Hu neuronopathy
Tiziana De Santis
368
STIFF PERSON SYNDROME IN A PATIENT WITH THYROIDITIS AND MISDIAGNOSED LADA. CASE REPORT
Antonio Iaffaldano
408
THE IMPORTANCE OF A NON-INVASIVE SCREENING IN PROXIMAL MIOPATHIES
Luca Lombardi
99
20 YEARS CLINICAL FOLLOW-UP IN PATIENTS WITH OCULOPHARYNGEAL MUSCLE DISEASE (OPMD)
Teresa Brizzi
74
Myotonic dystrophy type 2 in a cohort from southern Italy: a challenging diagnosis by biomolecular tests.
Fiammetta Biasini
11
Hereditary neuropathy with liability to pressure palsies: an atypical clinical presentation
Sergio Altomare
15
CLINICAL AND MOLECULAR INVESTIGATIONS IN ADULT AND JUVENILE DM1 PATIENTS
Corrado Angelini
35
Clinical variability in myotonic dystrophy type 1: a five-categories disease classification fits clinical but not brain complexity
Sigrid Baldanzi
36
Towards a definition of central and peripheral fatigue in myotonic dystrophy type 1 (DM1)
Sigrid Baldanzi
NEUROFISIOLOGIA CLINICA
8 poster
23
Cerebellar tDCS and Lokomat: effects on post-stroke recovery.
Bianca Aragona
86
SURROUND INHIBITION ABNORMALITIES IN FOCAL HAND DYSTONIA MAY NOT DEPEND BY ALTERATIONS IN SOMATOSENSORY INTEGRATION
Amelia Brigandi'
83
INTRAOPERATIVE NEUROPHYSIOLOGICAL MONITORING IN SPINE SURGERY: A SIGNIFICANT TOOL FOR NEURONAL PROTECTION AND FUNCTIONAL RESTORATION
Salvatore Bonvegna
371
Primary motor area map of Congenital Mirror Movements with MRI navigated TMS
Giovanna Chiara Ielo
561
Upper limb motor evoked potentials as a motor outcome in progressive MS
Marco Pisa
567
Electrophysiological characterization in hereditary spastic paraplegia can eventually address molecular diagnosis?
Alberto Polo
758
Spinal Direct Current Stimulation (tsDCS) in Hereditary Spastic Paraplegias (HSP): A Double-Blind, Sham-Controlled, Crossover Electrophysiological and Clinical Study
Maurizio Vergari
732
Combined facial and masseteric repetitive nerve stimulation in myasthenia gravis diagnosis: a 52 patients retrospective study.
Maria Claudia Trapasso
NEUROGENETICA
8 poster
716
Leukoencephalopathy with brain calcifications and cysts with SNORD188 mutations: a case report
Ilaria Taglia
624
Autosomal dominant cerebral small vessel disease associated with HTRA1 gene mutation in an Italian family
Silvia Romano
667
Ring chromosome 22 and Neurofibromatosis type II: a case report
Carla Schettino
543
ROLE OF MICRORNAs AND MUSCLE IMAGING IN LIPID STORAGE MYOPATHIES
Valentina Pegoraro
540
A novel heterozygous mutation in HTRA1 gene: a case report
Alba Rosa Pati
334
Identification of one novel mutation in GRN gene associated with frontotemporal dementia
Teresa Garcea
237
AARS2 mutation-related leukodystrophy: report of new adult-onset patients
I. Di Donato
288
Riluzole spinocerebellar ataxia type 7: report on two families
Michela Ferraldeschi
NEUROIMMAGINI
12 poster
270
Ultrasound diagnosis of post-operative complication of epineural repair in traumatic nerve lesions
Carmen Erra
276
The modulatory effect of cognitive reserve on the clinical outcome of patients with Traumatic Brain Injury: a voxel- based morphometry study
Chiara Falletta Caravasso
217
Different patterns of structural and microstructural damage in Neuromyelitis Optica Spectrum Disorders
Alessandro D'Ambrosio
366
Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis
Milagros Hidalgo De La Cruz
367
Dynamic functional network connectivity in CIS patients: a longitudinal study
Milagros Hidalgo De La Cruz
190
Structural MRI correlates of hand motor performance in patients with multiple sclerosis
Claudio Cordani
521
The role of the cerebellum in Alzheimer's disease cognitive decline: evidence from resting-state fMRI study
Giusy Olivito
711
A semi-automatic method to segment multiple sclerosis lesions on FLAIR magnetic resonance images
Loredana Storelli
631
Brain network topology in hereditary spastic paraparesis: a magnetoencephalography study
Rosaria Rucco
639
Automated machine learning approach for the prediction of early Multiple Sclerosis from resting state fMRI connectivity data
Valeria Saccà
640
Resting State fMRI head movements in Multiple Sclerosis patients: evaluation of the MCFLIRT correction algorithm
Valeria Saccà
765
Peak width of skeletonized mean diffusivity (PSMD), a novel imaging marker for cerebral small vessel disease: preliminary results in a CADASIL population
Claudia Vinciguerra
Neuroimmunologia e Neuroinfettivologia
16 poster
718
Sensory neuronopathy as sentinel symptom of primary Sjögren’s Syndrome: a case report
Irene Tempesta
754
Immune-mediated neuropathies after allogeneic hematopoietic stem cell transplantation: three case reports
Elisa Vegezzi
773
CEREBELLAR DEGENERATION SYNDROME ASSOCIATED TO ANTI-CV2 ANTIBODIES AND THYMOMA.
Domenica Zaino
714
A case of paraneoplastic limbic encephalitis mediated by anti-AMPAR antibodies: importance of early immunotherapy treatment
Andrea Sturchio
587
Intrathecal IgG synthesis in multiple sclerosis patients at clinical onset correlates with blood follicular T-cell subsets.
Marco Puthenparampil
179
Acute myelitis as presentation of measles, a reemerging disease
Irene Colombo
216
Clinical and serological characteristics of patients with double seronegative Myasthenia Gravis
Valentina Damato
116
Neurological complications of Varicella Zoster reactivation: a case series
Ilaria Callegari
120
Autoimmune encephalitis in a series of patients with rapidly progressive dementia: preliminary data from a prospective study
Giulia Camporese
124
Cytotoxic lesion of the corpus callosum: an atypical post-infectious neurologic syndrome.
Guglielmo Capaldo
6
Neuro-Behçet’s Disease presenting as an isolated progressive cognitive and behavioral syndrome
Lia Allegorico
18
Is an immunological dysfunction that damages vessel walls leading to thrombosis in a Sneddon syndrome?
Virginia Annese
378
Neurological Autoimmunity Associated With Thymoma: Beyond Myasthenia Gravis
Raffaele Iorio
399
Teleneurology is a valid tool to reduce the double burden of HIV and neurological disorders in subsaharan Africa
Massimo Leone
333
EASY TO DIAGNOSE AND TREAT, IF YOU THINK OF IT
Francesco Galmozzi
218
Central nervous system involvement in a case of Whipple disease
Clemente Dato
Neuroncologia
19 poster
397
Large cells neuroendocrine carcinoma (LCNEC) of dural sac presented as Froin's syndrome.
Luca Leonardi
103
COLLET-SICARD SYNDROME DUE TO METASTATIC SIGMOID CANCER: A CASE REPORT
Giorgia Bruno
110
Anaplastic astrocytoma mimicking Neuromyelitis Optica: a case report.
Corrado Cabona
129
Primary Brain Tumors in Neurological Setting: 8 years of clinical evaluation.
Salvatore Caratozzolo
159
Central Nervous System Hemangiopericytomas/Solitary Fibrous Tumors: a case series.
Carlotta Chiavazza
160
Rosenthal fibers in cervical enhancing myelopathic lesion: spondylosis or tumor?
Carlotta Chiavazza
557
Clinical heterogeneity of Bing Neel syndrome. A single-center experience
Alberto Picca
558
Neurological side effects of checkpoint inhibitor treatments: a case of Ipilimumab-related polyradiculoneuropathy
Alberto Picca
522
The cut-off value correlated with good favorable prognostic outcome in patients with newly diagnosis of glioma
Andrea Pace
472
An Evidence-Based Perspective of Curcumin for Neurofibromatosis 1 Patients
Marina Melone
681
Adult Medulloblastoma: an update from Italian Association of Neuroncology database.
Antonio Silvani
682
Familial brain tumor: a case report of homozygous twins affected by glioma
Antonio Silvani
683
Isaacs' syndrome associated with antibodies to Voltage-gated potassium channels (VGKC) in relapsing lymphoplasmacytic Lymphoma paziente
Antonio Silvani
684
Leptomeningeal carcinomatosis in adult Medulloblastoma: a monoistitutional experience of 33 patients
Antonio Silvani
645
De novo glioblastoma and relationship of anti-epileptic treatment with overall survival: a study on 290 patients from 3 Lombardia hospitals
Andrea Salmaggi
646
Ischaemic stroke of the anterior circulation 36 years after brain irradiation for a 3rd ventricular neoplasm: a case report
Andrea Salmaggi
634
A case of Lhermitte-Duclos disease (LDD) (dysplastic gangliocytoma of cerebellum) associated with syringomyelia
Marco Russo
635
Primary Central Nervous System Lymphoma (PCNSL) Mimicking Neuro-Behçet Disease
Marco Russo
764
Anti-SOX1 antibodies in a patient with neurolymphomatosis: just a coincidence?
Silvia Maria Villa
NEUROPSICOLOGIA CLINICA
16 poster
636
COGNITIION IN FRIEDREICH ATAXIA: A NEUROPSYCHOLOGICAL AND RS-FMRI STUDY
Francesco Saccà
637
The EDSS integration with the Brief International Cognitive Assessment for Multiple Sclerosis and Orientation Tests (iEDSS)
Francesco Saccà
679
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients
Mattia Siciliano
422
Neologisms in primary progressive aphasia: a possible clue to functional locus of lesion
Federica Lucchelli
447
THE EFFECTS OF BODY IMAGE CHANGES IN REHABILITATION OF NEUROLOGICAL DISORDER: A PRELIMINARY STUDY
Giuseppa Maresca
565
Differences in insight between frontotemporal dementia and progressive supranuclear palsy
Andrea Plutino
528
Multiple System Atrophy: cognitive impairment and comparison to Parkinson's Disease
Chiara Pane
577
The strange case of the "third hand". A case report.
Antonino Michele Previtera
123
Measuring sentence production in primary progressive aphasia
Elisa Canu
202
The cerebral correlates of the Subjective Experience of Time. A VLSM study in focal brain-damaged patients.
Claudio Crisci
191
Cognitive impairment screening in a cohort of multiple sclerosis outpatients: demographic characteristics, psychological features and relation to hospital care.
Francesco Corea
195
Exploring Mental Imagery in Relapsing Remitting Multiple Sclerosis
Teresa Costabile
370
REACHING TO REMEMBERED SPATIAL LOCATIONS IN A PATIENT WITH NEAR VISUAL SPACE NEGLECT AND OPTIC ATAXIA
Alessandro Iavarone
344
BRAIN AND MEMORY: A PILOT STUDY ON THE EXPERIENCE OF REBIRTH AND THE PRESENT LIFE QUALITY OF ADULT SUBJECTS
Alagona Giovanna
307
FROM NOVELTY SEEKING TO SELF TRASCENDENCE: REWARD DEPENDENCE MAY MAKE THE DIFFERENCE
Patrizia Fiori
214
Psychophysiological tests on Medjugorje seers. A critical appraisal.
Francesco D'Alpa
SCLEROSI MULTIPLA 1
23 poster
226
Regional grey matter atrophy in pediatric patients with multiple sclerosis: a longitudinal MRI study
Ermelinda De Meo
227
Regional patterns of brain atrophy development in pediatric and adult multiple sclerosis patients: a 3.5 year study
Ermelinda De Meo
294
Acceptability of first-line Disease-Modifying Drugs in Relapsing-Remitting Multiple Sclerosis: a real-life multicenter study
Diana Ferraro
296
Cell-specific transcriptional modulation induced by fingolimod treatment in Relapsing Remitting Multiple Sclerosis patients
Laura Ferrè
327
Neuroinflammation and neuroaxonal damage in multiple sclerosis: a cross-sectional cerebrospinal fluid-based proteomic study
Lorenzo Gaetani
318
Intrathecal oligoclonal bands synthesis: is it always a prognostic factor?
Jessica Frau
319
Pregnancy planning and outcome in MS patients after Mitoxantrone therapy.
Jessica Frau
410
A Metabolomic study of MS patients treated with fingolimod by high resolution NMR
Lorena Lorefice
201
Effect of glatiramer acetate on cerebral grey matter pathology progression in patients with relapsing-remitting multiple sclerosis: a 2-year monocenter study.
Francesco Crescenzo
112
Subclinical motor impairment assessed by an engineered glove correlates with MRI brain damage in radiologically isolated syndromes
Laura Bonzano
113
Dynamic volumetric changes of hippocampal subfields in CIS patients: a 2-year MRI study
Laura Cacciaguerra
21
Tolerability and persistence in therapy with PEGylated-IFN: results from a multicentric observational study in Northern Italy
Pietro Annovazzi
580
Dimethyl fumarate vs. fingolimod in multiple sclerosis: an independent, multicentre, real world, quasi-randomized study
Luca Prosperini
581
Minimal or No Evidence of Disease Activity: which target to prevent long-term disability in multiple sclerosis?
Luca Prosperini
539
Cognitive reserve is associated with better cognitive outcome and socio-professional attainment in both adult and pediatric-onset multiple sclerosis
Luisa Pasto'
551
Association between cortical lesions and GABA concentration in progressive multiple sclerosis.
Maria Petracca
435
Reversible Effects of Daclizumab beta on Lymphocyte Counts in RRMS Patients: Data From the SELECT Trilogy Studies
Giulia Mallucci
412
Multiple Sclerosis and HLA genotypes: a possible influence on brain atrophy
Lorena Lorefice
481
Oxidative stress in multiple sclerosis: effect of dietary supplementation with coenzyme Q10
Marcello Moccia
692
Participants' perspectives on a home-based palliative approach for people with severe multiple sclerosis: a qualitative study nested in a randomized controlled trial
Alessandra Solari
699
Validation of the Italian version of the Patient Determined Disease Steps scale in people with Multiple Sclerosis
Maddalena Sparaco
619
Patterns of regional gray matter and white matter atrophy in patients starting fingolimod or natalizumab: a 2-year tensor-based morphometry study
Maria Assunta Rocca
729
Anti-MOG antibodies are not rare in isolated optic neuritis and myelitis and induce complement mediated demyelination.
Carla Tortorella
SCLEROSI MULTIPLA 2
23 poster
586
Interim Report on the Safety and Efficacy of Long"term Daclizumab beta Treatment for up to 5 Years (EXTEND Trial)
Marco Puthenparampil
691
Equivalence of the electronic versus paper-based short version of the MSQOL-54 (MSQOL-29)
Alessandra Solari
478
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study.
Massimiliano Mirabella
480
A 8-year retrospective cohort study comparing Interferon-ß formulations for relapsing-remitting multiple sclerosis
Marcello Moccia
414
Timed up and go and brain atrophy: a preliminary MRI study to assess functional mobility performance in Multiple Sclerosis
Lorena Lorefice
424
Role of the anti-Myelin Oligodendrocyte glycoprotein (MOG) antibodies and anti-Aquaporin 4 (AQP4) antibodies in idiopathic isolated optic neuritis and myelitis: serum biomarkers of specific clinical syndromes?
Elena Luciannatelli
434
Dimethyl fumarate safety, tolerability and efficacy: two-year real life analysis in Northern-Italy
Giulia Mallucci
588
Neurofilament light chain levels associate to white matter pathology in multiple sclerosis at clinical onset.
Marco Puthenparampil
601
Efficacy of Daclizumab beta vs Intramuscular Interferon Beta"1a on 24"Week Sustained Disability Progression Using a Modified Multiple Sclerosis Functional Composite
Anna Repice
27
Impact of MRI activity on cognitive functions in Multiple Sclerosis
Mauro Arru
20
Multiple Sclerosis treatment management in women of fertile age: do neurologists and patients priorities coincide?
Pietro Annovazzi
105
Cutaneous Events in Daclizumab beta"Treated Patients Did Not Impact Patient"Reported Outcomes in the DECIDE Study
Sebastiano Bucello
58
What is the impact of menopause on multiple sclerosis? A multicentre retrospective observational study
Damiano Baroncini
126
DETECTION OF ANTI MOG ANTIBODIES IN DEMYELINATING DISORDERS OF THE CENTRAL NERVOUS SYSTEM (CNS)
Marco Capobianco
171
Impact of brain atrophy on cognitive motor interference in multiple sclerosis: a dual task study.
Giancarlo Coghe
411
Biological rhythms in MS patients with mood disorders: what impact on quality of life?
Lorena Lorefice
387
Cognitive impairment does not predict short term clinical outcome in early onset multiple sclerosis.
Roberta Lanzillo
388
The RESPECT study: a multi-centRE observational analysiS of PErsistenCe to Treatment in the new MS drugs era.
Roberta Lanzillo
364
Neurodegeneration and demyelination along the visual pathway are more prominent in secondary progressive than primary progressive multiple sclerosis
Simone Guerrieri
323
Cognitive impairment in MS, performance in daily activity and perception: a patient/caregiver study.
Marzia Fronza
278
Epidemiological features and therapeutic strategies in a population of Multiple Sclerosis patients from three Provinces of Veneto Region (Italy): preliminary results.
Gabriele Farina
285
A longitudinal study correlating brain volumes, RNFL, and cognitive functions in MS patients and healthy controls
Giuseppe Fenu
286
Is it time to include Visual Evoked Potentials in MS diagnostic Criteria?
Giuseppe Fenu
SCLEROSI MULTIPLA 3
18 poster
239
A real-life retrospective study on patients with Relapsing-Remitting Multiple Sclerosis treated with Natalizumab: how much the JCV status antibodies influence the clinical choice?
Maria Di Gregorio
240
BENEFICAL EFFECTS OF ADAPTED PHYSICAL ACTIVITY ON PHYSICAL AND COGNITIVE ASPECTS OF MULTIPLE SCLEROSIS: RESULTS OF A PRELIMINARY STUDY CARRIED OUT IN COLLABORATION WITH THE ITALIAN MULTIPLE SCLEROSIS ASSOCIATION - PERUGIA SECTION.
Maria Di Gregorio
339
Managing the transition to secondary progressive multiple sclerosis: a scoping review
Andrea Giordano
340
Rapidly progressive visual worsening in a patient with multiple sclerosis (pwMS): an insight into progressive disease.
Antonino Giordano
369
Profiling treatment choices in MS during two different eras: a real world assessment in the Italian MS Registry
Pietro Iaffaldano
405
In fully ambulatory RR-MS patients, 3D gait analysis may detect wors parameters of stability compared to HC.
Marianna Liparoti
172
Impact of sleep characteristics on quality of life of patients with multiple sclerosis.
Giancarlo Coghe
59
Hepatic microabscesses during CMV reactivation in a multiple sclerosis patient after alemtuzumab treatment
Stefania Barone
24
Emotional recognition in MS: neural correlates in RR and SP patients.
Ornella Argento
529
Lymphocyte count as biomarker of MRI activity in a Multiple Sclerosis Dimethyl-Fumarate-treated cohort
Damiano Paolicelli
530
Real life experience of the impact of Body Mass Index in Fingolimod-induced lymphopenia in Multiple Sclerosis patients
Damiano Paolicelli
541
Administration of IFN beta 1a in the evening ameliorates flu-like symptoms in the early phase of treatment in multiple sclerosis: data from RELIEF study
Francesco Patti
413
Progressive Multifocal Leukoencephalopathy during Teriflunomide in Multiple Sclerosis Patient: case report
Lorena Lorefice
443
No evidence for skin malignancies during Fingolimod in Multiple Sclerosis: data from real life
Alessia Manni
504
Enhancing brain plasticity to contrast clinical progression in MS: a pilot study assessing the safety and efficacy of D-Aspartate
Carolina Gabri Nicoletti
620
Revised McDonald 2010 versus MAGNIMS 2016 MRI criteria in CIS patients suggestive of MS: a multicenter study
Maria Assunta Rocca
618
Anticipation of long-term disability progression in PPMS using MRI: a 15-year longitudinal study
Maria Assunta Rocca
775
COMORBIDITY PREVALENCE IN A MULTIPLE SCLEROSIS CENTER
Clara Zanchi
SCLEROSI MULTIPLA 4
16 poster
741
The effectiveness of natalizumab and fingolimod in relapsing-remitting multiple sclerosis. An observational, multicentre Italian study.
Elena Tsantes
638
Application of Shape analysis in Multiple Sclerosis: evaluation of hippocampal atrophy
Valeria Saccà
657
Expression Profile of Long Non-Coding RNAs (lncRNAs) in Serum of Patients with Multiple Sclerosis
Massimo Santoro
680
Adiponectin as a possible biomarker in Multiple Sclerosis
Elisabetta Signoriello
421
Sativex® effects on promoter methylation and on CNR1/CNR2 expression in periphereal blood mononuclear cells of progressive multiple sclerosis patients
Francesco Antonio Losavio
593
A Retrospective Comparison of Rituximab Vs Cyclophosphamide In Neuromyelitis Optica Spectrum Disorders Patients
Marta Radaelli
573
The unmet needs of Elderly People with Multiple Sclerosis
Michela Ponzio
583
Alemtuzumab induces a persistent total suppression of T follicular regulatory lymphocytes in multiple sclerosis patients.
Marco Puthenparampil
3
CARDIOVASCULAR PROFILE IMPROVEMENT DURING NATALIZUMAB TREATMENT
Roberto Albero
162
Cancer evaluation in Multiple Sclerosis patients: effect on clinical outcomes
Clara Grazia Chisari
163
Comorbidity evaluation in Multiple Sclerosis patients: effect on clinical outcomes
Clara Grazia Chisari
146
Long term efficacy of fingolimod for the treatment of multiple sclerosis: results from a single- cohort observational study
Maria Cellerino
212
Prognostic factors for multiple sclerosis in patients with isolated spinal syndromes
Gloria Dalla Costa
208
Spinal cord lesions are frequently asymptomatic in relapsing-remitting multiple sclerosis. A retrospective MRI survey.
Erica Curti
354
Central vein sign evaluation by brain MRi for the differential diagnosis of multiple sclerosis cases with markers of “better explanation" of the disease.
Matteo Grammatico Di Tullio
282
Natalizumab is highly effective on clinical, MRI and neuropsychological outcomes in relapsing remitting multiple sclerosis patients.
Lisa Federle
SCLEROSI MULTIPLA 5
19 poster
314
Arthritic psoriasis during Natalizumab (NZ) treatment: a case report and literature review of disease modifying treatment long-term cutaneous adverse reactions.
Matteo Foschi
317
Clinical activity after Fingolimod cessation: disease reactivation or rebound?
Jessica Frau
381
Lymphocytes subsets after one year of dimethylfumarate treatment in multiple sclerosis: a real life study.
Sara La Gioia
382
Regression of erythroblastaemia in natalizumab-treated patients with multiple sclerosis after drug suspension.
Sara La Gioia
138
Eosinophilic gastroenteritis dimethylfumarate induced: a case report.
Sara Casertano
164
Modeling of upper limbs motor function in Multiple Sclerosis patients using movement time analyzer (MTA): a pilot study.
Clara Grazia Chisari
10
Co-occurrence of progressive Multiple Sclerosis (MS) and neurofibromatosis type 1 (NF1) in a patient with serum anti-Myelin Oligodendrocyte Glycoprotein antibodies (MOG-Abs).
Sergio Altomare
13
Paroxysmal dystonia as first symptom of multiple sclerosis: presenting two cases
Annalisa Amidei
47
A case of demyelinating myelopathy during treatment with Tumor Necrosis Factor -a blokers
Paola Banfi
71
THE BIO-BANK OF CRESM: A TOOL TO FACILITATE THE RESEARCH IN MULTIPLE SCLEROSIS
Antonio Bertolotto
584
Alemtuzumab infusion associates with transitory platelet count reduction
Marco Puthenparampil
585
CNS-derived MicroVescicles proteins in the Cerebrospinal Fluid of multiple sclerosis patients: new promising biomarkers in Relapsing Remitting Multiple Sclerosis.
Marco Puthenparampil
602
A 6-years follow-up of relapsing remitting multiple sclerosis identifies Word List Generation test and EDSS as best predictors of progressive disease phase.
Alice Riccardi
437
Assessment of dysautonomic symptoms in MS patients by means of the Composite Autonomic Symptom Score (COMPASS)-31 questionnaire
Luca Mancinelli
442
The application of Kübler-Ross model in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis.
Giorgia Teresa Maniscalco
503
Cannabinoid CB1 receptors improve anxiety and affective component of neuropathic pain by tDCS in MS
Carolina Gabri Nicoletti
509
Tocilizumab in refractory anti-MOG neuromyelitis optica spectrum disorder: a case report
Giovanni Novi
471
Mentalizing in Multiple Sclerosis
Riccardo Fabrizio Meli
715
Conversion Time from Optic Neuritis to Clinically Definite Multiple Sclerosis: search for predictors
Andrea Sturchio
Filtra l’elenco dei contenuti per
Titolo
Autori (cognome)
Realizzazione:
TESISQUARE®
Per assistenza scrivere al
Supporto Tecnico